Novartis is sharing information and resources to empower people affected by prostate cancer during Prostate Cancer Awareness Month

The Novartis 2022 Day of Reflection highlighted the company’s commitment to making DEI a movement not a moment.

At Novartis, our common humanity is what connects all of us. We will continue to stand in solidarity with all people who find themselves in the path of injustice, inequity or violence. The Day of Reflection, Forward Together is an opportunity for everyone to engage in listening and learning.

The Novartis US Foundation has partnered with the Institute for Healthcare Improvement to help healthcare systems better serve patients.

Novartis begins U.S. pilot program for OdySight, a clinically tested mobile application designed to help monitor vision remotely.

Vas Narasimhan reflects on how to increase diversity in clinical trials

After years of decline, cardiovascular disease mortality is on the rise, with a disproportionate impact on Black Americans

Novartis is striving every day to help patients, strengthen communities, drive sustainability and build a more equitable healthcare system for all.

The Novartis US Foundation partners with local groups to improve healthcare in underserved communities, including by expanding use of telemedicine.

Novartis is fighting COVID-19 broadly, from committing R&D resources to better understand and treat the disease to reaching out to individuals and communities in need.

More than 16 teams from US universities participated in the first US oncology data science hackathon to tackle current challenges in metastatic breast cancer treatments.

On this Day of Reflection, Novartis associates are thinking and talking about what it means to be part of a truly diverse and inclusive organization.